These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12145279)

  • 1. A major functional difference between the mouse and human ARF tumor suppressor proteins.
    Wadhwa R; Sugihara T; Hasan MK; Taira K; Reddel RR; Kaul SC
    J Biol Chem; 2002 Sep; 277(39):36665-70. PubMed ID: 12145279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathway.
    Sugihara T; Kaul SC; Kato J; Reddel RR; Nomura H; Wadhwa R
    J Biol Chem; 2001 Jun; 276(22):18649-52. PubMed ID: 11259404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
    Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R
    J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ARF-p53 senescence pathway in mouse and human cells.
    Wadhwa R; Sugihara T; Taira K; Kaul SC
    Histol Histopathol; 2004 Jan; 19(1):311-6. PubMed ID: 14702199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.
    Kamrul HM; Wadhwa R; Kaul SC
    Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and physical interaction of the human ARF tumor suppressor with Tat-binding protein-1.
    Pollice A; Nasti V; Ronca R; Vivo M; Lo Iacono M; Calogero R; Calabrò V; La Mantia G
    J Biol Chem; 2004 Feb; 279(8):6345-53. PubMed ID: 14665636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM activity contributes to the tumor-suppressing functions of p14ARF.
    Li Y; Wu D; Chen B; Ingram A; He L; Liu L; Zhu D; Kapoor A; Tang D
    Oncogene; 2004 Sep; 23(44):7355-65. PubMed ID: 15258567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
    Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
    J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein.
    Vivo M; Calogero RA; Sansone F; Calabrò V; Parisi T; Borrelli L; Saviozzi S; La Mantia G
    J Biol Chem; 2001 Apr; 276(17):14161-9. PubMed ID: 11278317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control.
    Hasan MK; Yaguchi T; Minoda Y; Hirano T; Taira K; Wadhwa R; Kaul SC
    Biochem J; 2004 Jun; 380(Pt 3):605-10. PubMed ID: 15109303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
    Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
    Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
    Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
    Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
    Kamijo T; Zindy F; Roussel MF; Quelle DE; Downing JR; Ashmun RA; Grosveld G; Sherr CJ
    Cell; 1997 Nov; 91(5):649-59. PubMed ID: 9393858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.
    Rizos H; Darmanian AP; Mann GJ; Kefford RF
    Oncogene; 2000 Jun; 19(26):2978-85. PubMed ID: 10871849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.